Sequent Scientific Limited (SEQUENT.NS)
ValueMarkers Composite Index
3072% above intrinsic value ($6)
Sequent Scientific Limited operates animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Deep Dive Analysis
DCF Analysis
Intrinsic value estimate, margin of safety, and key valuation metrics.
Piotroski F-Score
9-point financial strength test across profitability, leverage, and efficiency.
Quality Triple Check
Piotroski F-Score + Altman Z-Score + Beneish M-Score combined assessment.
Valuation Analysis
Complete multiples breakdown - P/E, P/B, EV/EBITDA, yield metrics, and intrinsic value.